The Phases of GI Clinical Trials: From Phase I to Phase IV

Erick Alayo • November 17, 2026

Short answer: a clinical trial moves through up to four phases. Each phase answers a different question, from "is it safe?" to "does it keep working over time?" Knowing the phase helps you understand what a study is asking of you.

Phase I: Is it safe?

Phase I studies usually enroll a small group, often a few dozen people. Researchers look at safety, how the body handles the treatment, and which dose is tolerated. Participants are monitored closely, with frequent visits and tests.

Phase II: Does it seem to work?

Phase II enrolls more people who have the condition being studied, such as gastroparesis, ulcerative colitis or GERD. The goal is to see early signs of benefit while continuing to track side effects.

Phase III: How does it compare?

Phase III studies are larger and often compare the new treatment with a standard treatment or a placebo. Many are randomized , meaning a computer, not the doctor or the patient, decides which group you join. Some are also blinded , so neither you nor the study team knows which treatment you receive until the study ends. This protects the accuracy of the results.

Phase IV: What happens over time?

After a treatment is approved, Phase IV studies follow patients for longer to learn about rare side effects and long-term results in everyday practice.

What this means for you

  • Every study has a written protocol that lists who can join and what visits and tests are required.
  • Joining is voluntary, and you can leave at any time.
  • Ask the research team which phase the study is, what is being tested, and what the possible risks are.

Questions about a study?

The team at Gastro SB Clinical Research in Chula Vista, California can explain how screening works and whether a study may fit your situation. Contact us at info@gastrosbclinicalresearch.com.

This article is educational and does not replace medical advice from your doctor.